pioglitazone has been researched along with Airway Remodeling in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Airway Remodeling: The structural changes in the number, mass, size and/or composition of the airway tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Peroxisome proliferator-activated receptor-γ (PPARγ) agonist pioglitazone (PGZ) exhibits potential protective effects in asthma." | 3.88 | PPARγ Agonist PGZ Attenuates OVA-Induced Airway Inflammation and Airway Remodeling via RGS4 Signaling in Mouse Model. ( Deng, W; Fang, P; Liu, Y; Meng, X; Shi, H; Sun, X; Wang, G; Yang, S; Zhang, Y, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meng, X | 1 |
| Sun, X | 1 |
| Zhang, Y | 1 |
| Shi, H | 1 |
| Deng, W | 1 |
| Liu, Y | 1 |
| Wang, G | 1 |
| Fang, P | 1 |
| Yang, S | 1 |
1 other study available for pioglitazone and Airway Remodeling
| Article | Year |
|---|---|
PPARγ Agonist PGZ Attenuates OVA-Induced Airway Inflammation and Airway Remodeling via RGS4 Signaling in Mouse Model.
Topics: Airway Remodeling; Animals; Asthma; MAP Kinase Signaling System; Mice; Ovalbumin; Pioglitazone; PPAR | 2018 |